These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18451670)

  • 1. Determinants of insulin resistance and its effects on protein metabolism in patients with advanced chronic kidney disease.
    Siew ED; Ikizler TA
    Contrib Nephrol; 2008; 161():138-144. PubMed ID: 18451670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease.
    Siew ED; Ikizler TA
    Semin Dial; 2010; 23(4):378-82. PubMed ID: 20701717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glucose homeostasis on protein metabolism in patients with advanced chronic kidney disease.
    Ikizler TA
    J Ren Nutr; 2007 Jan; 17(1):13-6. PubMed ID: 17198926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance in chronic kidney disease: a systematic review.
    Spoto B; Pisano A; Zoccali C
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1087-F1108. PubMed ID: 27707707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in chronic kidney disease.
    Xu H; Carrero JJ
    Nephrology (Carlton); 2017 Dec; 22 Suppl 4():31-34. PubMed ID: 29155496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic derangements seen in chronic kidney disease and end-stage renal disease patients.
    Gupta D; Misra M
    Contrib Nephrol; 2011; 171():113-119. PubMed ID: 21625099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and insulin resistance as novel mechanisms of wasting in chronic dialysis patients.
    da Costa JA; Ikizler TA
    Semin Dial; 2009; 22(6):652-7. PubMed ID: 20017836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do metabolic derangements in end-stage polycystic kidney disease differ versus other primary kidney diseases?
    Jankowska M; Qureshi AR; Barany P; Heimburger O; Stenvinkel P; Lindholm B
    Nephrology (Carlton); 2018 Jan; 23(1):31-36. PubMed ID: 27653449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure.
    Kalantar-Zadeh K; Mehrotra R; Fouque D; Kopple JD
    Semin Dial; 2004; 17(6):455-65. PubMed ID: 15660576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Nutrition and Malnutrition in CKD and ESRD.
    Zha Y; Qian Q
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance as a therapeutic target for chronic kidney disease.
    Teta D
    J Ren Nutr; 2015 Mar; 25(2):226-9. PubMed ID: 25511524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin and its role in chronic kidney disease.
    Mak RH
    Pediatr Nephrol; 2008 Mar; 23(3):355-62. PubMed ID: 17929061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors determining insulin resistance in chronic hemodialysis patients.
    Hung AM; Ikizler TA
    Contrib Nephrol; 2011; 171():127-134. PubMed ID: 21625101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein and energy intake in advanced chronic kidney disease: how much is too much?
    Ikizler TA
    Semin Dial; 2007; 20(1):5-11. PubMed ID: 17244111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin resistance and inflammation in chronic kidney diseases].
    Guebre-Egziabher F; Kalbacher E; Fouque D
    Nephrol Ther; 2009 Jul; 5 Suppl 5():S346-52. PubMed ID: 19761971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
    Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
    Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients.
    Lee SW; Park GH; Lee SW; Song JH; Hong KC; Kim MJ
    Nephrol Dial Transplant; 2007 Sep; 22(9):2554-62. PubMed ID: 17438006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.